U.S. advisers say keep Glaxo's Avandia on market

Wednesday, July 14, 2010 - 15:56 in Psychology & Sociology

U.S. health advisers said GlaxoSmithKline Plc's GSK.L diabetes drug Avandia should be allowed to stay on the market in some form, easing a threat of further litigation that could have followed a ban.

Read the whole article on LA Times - Health

More from LA Times - Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net